Lv1
70 积分 2023-06-25 加入
Confirmatory Evidence Used in Non-Oncologic Rare Disease New Molecular Entity Marketing Applications Approved by FDA, 2020–2023
6天前
已完结
Radiotheranostic landscape: A review of clinical and preclinical development
7天前
已完结
Responder Analyses Can Be Misleading
1个月前
已完结
Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration
1个月前
已完结
Responder Analyses Can Be Misleading
1个月前
已完结
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
3个月前
已完结
国内外已上市连续制造口服固体制剂药学审评内容的研究与启示
4个月前
已完结
抗肿瘤抗体偶联药物临床药理学研究的若干问题与考虑
4个月前
已完结
人因工程应用于药械组合产品开发中的启示
4个月前
已完结
皖公网安备34019202002308
